SyncThink Scores FDA Breakthrough Device Designation for Concussion Tech

FDA has granted a breakthrough device designation to SyncThink's Eye-Sync technology. The objective eye-tracking platform is currently used to assist clinicians in evaluating visual impairments, monitor recovery and support the rehabilitation of ocular-motor and ocular-vestibular deficits, and in the optimization of brain performance.